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Identification of human exercise-induced myokines using secretome
analysis. Physiol Genomics 46: 256–267, 2014. First published Feb-
ruary 11, 2014; doi:10.1152/physiolgenomics.00174.2013.—Endur-
ance exercise is associated with significant improvements in cardio-
metabolic risk parameters. A role for myokines has been hypothe-
sized, yet limited information is available about myokines induced by
acute endurance exercise in humans. Therefore, the aim of the study
was to identify novel exercise-induced myokines in humans. To this
end, we carried out a 1 h one-legged acute endurance exercise
intervention in 12 male subjects and a 12 wk exercise training
intervention in 18 male subjects. Muscle biopsies were taken before
and after acute exercise or exercise training and were subjected to
microarray-based analysis of secreted proteins (secretome). For acute
exercise, secretome analysis resulted in a list of 86 putative myokines,
which was reduced to 29 by applying a fold-change cut-off of 1.5.
Based on that shortlist, a selection of putative myokines was measured
in the plasma by ELISA or multiplex assay. From that selection,
CX3CL1 (fractalkine) and CCL2 (MCP-1) increased at both mRNA
and plasma levels. From the known myokines, only IL-6 and FGF 21
changed at the mRNA level, whereas none of the known myokines
changed at the plasma level. Secretome analysis of exercise training
intervention resulted in a list of 69 putative myokines. Comparing
putative myokines altered by acute exercise and exercise training
revealed a limited overlap of only 13 genes. In conclusion, this study
identified CX3CL1 and CCL2 as myokines that were induced by acute
exercise at the gene expression and plasma level and that may be
involved in communication between skeletal muscle and other organs.
myokine; acute exercise; skeletal muscle; CX3CL1; CCL2
PHYSICAL EXERCISE CAN SERVE as a very powerful tool in the
prevention and treatment of metabolic diseases, including obe-
sity and Type 2 diabetes. In Type 2 diabetic patients, exercise
increases insulin sensitivity in liver and muscle (22), improves
cardiorespiratory fitness and cardiovascular health (44), and
reduces dyslipidemia (2, 10). While skeletal muscle is the
predominant organ affected by acute exercise, specific meta-
bolic alterations elicited by exercise may be accounted for by
changes at the level of other organs such as the liver and
adipose tissue. Very little is known about mechanisms of cross
talk between muscle and other organs that could underlie
effects of exercise on systemic health.
One possible mechanism is via secretion of proteins that
signal between muscle and the rest of the body. A recent
publication showed that acute exercise not only changes gene
expression in the exercising muscle, but also in the nonexer-
cising muscle (8), supporting a cross talk between active
skeletal muscle and inactive organs. In recent years, it has
become clear that skeletal muscle releases a variety of proteins
into the circulation. These proteins are referred to as myokines
and represent putative “exercise factors” (17, 28, 49). To serve
as exercise factor, production of the myokine should be altered
upon muscle contraction and/or by chronic exercise training. A
number of myokines have been shown to be released from
muscle during and shortly after exercise, with interleukin-6
(IL-6) being the most prominent example (12). Evidence sug-
gests that IL-6 released from muscle during exercise may
contribute to the exercise-induced increase in hepatic glucose
production (41). Other presumed myokines include IL-8, IL-15
(26), leukemia inhibitory factor (LIF) (27), and fibroblast
growth factor 21 (FGF-21) (15). None of these factors are
solely produced by muscle, and all have major functions
elsewhere in the body. Due to their potential as pharmacolog-
ical targets, there is an on-going quest to find additional
myokines, and studies are undertaken to determine their role
during acute exercise and in the adaptive response to chronic
exercise training.
Different approaches toward identification of novel myo-
kines have been pursued, mainly focusing on animal models or
on cultured myocytes subjected to electrical pulse stimulation
(1, 6, 13, 25, 33). The studies undertaken in humans focus on
specific genes and proteins (7, 21, 42) or are limited to exercise
training (4, 25). So far no untargeted screenings have been
undertaken to identify novel myokines during acute exercise in
humans. Furthermore, there are no data on myokines com-
monly regulated by acute exercise and exercise training. Myo-
kines increasing in both exercise modalities would be highly
interesting targets for development of exercise mimetics and
are also prime candidates to serve as general exercise (bio-
)marker.
Accordingly, in this study we have utilized the one-legged
exercise model and performed whole genome gene expression
analysis in pre- and postexercise muscle biopsies to screen for
new putative myokines in humans. We compared results of the
myokine screening of the acute one-legged exercise with a
myokine screening of a 12 wk exercise training intervention, to
assess the overlap between acutely and chronically induced
myokines. The overall results of the whole genome gene
expression analysis of the one-legged cycling have been pub-
lished elsewhere (8). The present paper is focused specifically
on the study of myokines. Our results point to a number of
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novel myokines that may be involved in cross talk between
skeletal muscle and other organs.
METHODS
Acute exercise intervention. Twelve healthy middle-aged men [age
51.5  5.1 yr, body wt 88  17 kg, body mass index (BMI) 26  4
kg/m2; average  SD] participated in the study. Inclusion criteria
were: between 40 and 60 yr of age, BMI 30 kg/m2, and male sex.
Subjects had an average maximal oxygen uptake of 35  10
ml·min1·kg1 and were sedentary to moderately active (not more
than 3 h of exercise per week). Subjects did not use any medicine, nor
did they smoke. More details about the study population can be found
elsewhere (8). This age group was chosen because they are part of the
population mostly affected by diseases such as obesity and diabetes
Type 2 and at the same time are able to perform more intense exercise
without causing potential health risks. The study was approved by the
medical ethical committee of Wageningen University, and all subjects
received oral and written information about the experimental proce-
dures and provided written informed consent.
Detailed microarray analysis of this study was published elsewhere
(8). This study is a detailed follow-up on that article to provide more
insight on the myokines induced by exercise. All subjects performed
a single 60 min experimental endurance exercise bout, which was
preceded by two preliminary exercise tests and two familiarization
trials. During the endurance exercise bout subjects had to perform
one-legged cycling at 50% of maximal wattage reached during a
one-legged maximal exercise test on a cycle ergometer (Excalibur
Sport; Lode, Groningen, NL), adapted with a custom-made leg sup-
port. Exercise was reported to be fairly difficult and subjects reached
a maximum of 60% of the heart rate reserve after 1 h. Skeletal
muscle biopsies were taken from both legs before and within 15 min
after exercise. Subjects were fasted during the whole experimental
exercise bout, in total for 15 h, and had ad libitum access to water.
Temperature in the exercise room was 20°C.
Exercise training intervention. Eighteen healthy middle-aged male
subjects (at baseline: age 59  3.7 yr, weight 95.1  12 kg, BMI
29.8  6.6 kg/m2, V̇O2 max 28.9  4.4 ml·min1·kg1; average  SD)
performed a 12 wk combined exercise training intervention. The 18
healthy subjects participated in a larger study and were matched for
age, BMI, and maximal oxygen uptake with 18 diabetic subjects. The
combined exercise training consisted of two endurance exercise ses-
sions and one resistance exercise session per week (45 min per
session). More details about the study and participants can be found in
Meex et al. (22).
Tissue collection. Blood was collected in EDTA-containing tubes.
The samples were immediately centrifuged at 1,000 g at 4°C for 10
min, after which plasma was stored in 80°C until further analysis.
For the acute exercise study, percutaneous needle biopsies were
taken before (T0) and shortly after exercise (T1) from both legs (4
biopsies in total). For the exercise training study, needle biopsies were
taken before and 3 days after termination of the training period after
an overnight fast. Biopsies were collected from the vastus lateralis
muscle by the Bergström technique with suction (23). All biopsies
were taken from a separate incision. After collections biopsies were
immediately frozen into liquid nitrogen and stored at 80°C for
further analysis. We were not able to collect muscle biopsies of one of
the participants due to hypersensitivity of the participant to the biopsy
procedure.
RNA extraction, microarray processing, and microarray data analysis.
RNA extraction, microarray processing, and microarray analysis for
the acute exercise study are described in detail elsewhere (8). In short,
RNA was isolated with Trizol and purified with RNeasy columns,
after which RNA was labeled and hybridized to human whole genome
Genechip Human Gene 1.1 ST arrays coding 19.732 genes (Af-
fymetrix, Santa Clara, CA). Microarray analysis was performed using
MADMAX pipeline for statistical analysis of microarray data (19).
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Fig. 1. Secretome analysis reveals a large number of new putative myokines in
the acute exercise study. Flow chart showing the various steps for identifying
new myokines. Genes were considered significantly changed when P  0.01.
T0, before exercise; T1, directly after exercise. Data set was filtered using
expression value cut-offs  20 on  5 arrays, and an interquartile range of 0.2
was applied. Exercising leg n  9, nonexercising leg n  7.
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Quality control was performed, and all arrays met our criteria, except
arrays from two participants from the acute exercise intervention that
showed a clearly distinct clustering and pattern after normalization.
Those microarrays were excluded from further analysis. Microarray
data were filtered (expression values 20 on 5 arrays, interquartile
range  0.2). Significant differences in expression were assessed
using intensity-based moderated t-statistic (IBMT) (35). Genes were
defined as significantly changed when the P value was  0.01.
Differences in gene expression between the legs were determined by
a paired IBMT test on the difference between T0 and T1 for both legs
(P  0.05). The microarray dataset is MIAME compliant and has
been submitted to the Gene Expression Omnibus (accession number
GSE41769).
Several participants were excluded through the pipeline of the
acute exercise study. The study started with 12 participants. One
participant was excluded due to hypersensitivity to the biopsy proce-
dure, two participants were excluded based on a distinct clustering in
the quality control of the microarray, and two participants were
excluded solely in the nonexercising leg based on their aberrant
response to exercise in that leg [rationale in Catoire et al. (8)], leaving
the acute exercise study with n  9 for the exercising leg and n  7
for the nonexercising leg.
The processing and analysis of the muscle biopsies derived from
the exercise training study were as described above. All samples
passed quality control. The microarray data were filtered (expression
values 20 on 5 arrays, interquartile range  0.2) and subjected to
statistical analysis (P  0.01). The primary microarray dataset was
submitted to Gene Expression Omnibus (GSE53598).
cDNA synthesis and quantitative real-time PCR. Total RNA was
reverse transcribed with a cDNA synthesis kit (Promega, Leiden, NL).
Standard quantitative (q)PCR was performed using SensiMix real-
time PCR reagents (Bioline, London, UK) and a Bio-Rad CFX384
machine (Bio-Rad Laboratories, Veenendaal, NL). Primer sequences
were based on availability in the PRIMERBANK (http://pga.mgh.
harvard.edu/primerbank/index.html) and can be found in Table 1.
GAPDH was used as housekeeping gene, as its expression did not
change upon acute exercise or exercise training (measured by qPCR
and/or microarray)
Secretome analysis. We performed microarray-based secretome
analysis on all significantly changed genes in the acute exercise and
training studies by screening for genes likely encoding secreted
proteins using Gene Ontology (GO) Classification and SignalP pre-
dicting tools. Specifically, significantly changed genes annotated in
GO Cellular Component as extracellular region or space (GO:
0005576/GO:0005615) were selected. Remaining genes that were not
assigned to a GO category were screened for presence of a signal
peptide with SignalP (3).
Gene name Description E NE FC E FC NE Muscle specific
ANGPTL4 angiopoietin-like 4 1.6* 3.5 NO
SEMA3F sema domain, immunoglobulin domain (Ig), short basic domain, 3F 1.5* 1.2 NO
ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 4.9* 1.3 NO
CYR61 cysteine-rich, angiogenic inducer, 61 3.0* -1.5 NO
APOLD1 apolipoprotein L domain containing 1 2.5* 1.3 NO
THBD thrombomodulin 2.0* 1.3 NO
FGF6 fibroblast growth factor 6 1.9 1.4 NO
CXCL2 chemokine (C-X-C motif) ligand 2 1.9* 1.0 NO
DLL1 delta-like 1 (Drosophila) 1.8* 1.4 NO
LOC100505657 hypothetical protein LOC100505657 1.8* 1.2 ?
CX3CL1 chemokine (C-X3-C motif) ligand 1 1.8* -1.2 NO
THBS1 thrombospondin 1 1.8 1.3 **
SMPDL3A sphingomyelin phosphodiesterase, acid-like 3A 1.7* 1.1 NO
CCL2 chemokine (C-C motif) ligand 2 1.7 1.0 NO
VEGFA vascular endothelial growth factor A 1.6* 1.3 NO
HSPH1 heat shock 105kDa/110kDa protein 1 1.6* 1.0 NO
ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 1.6* 1.1 NO
GDNF glial cell derived neurotrophic factor 1.6* 1.2 NO
CRISPLD2 cysteine-rich secretory protein LCCL domain containing 2 1.5# 1.1 NO
SDC4 syndecan 4 1.5* 1.2 NO
CTGF connective tissue growth factor 1.5* -1.2 **
PLAU plasminogen activator, urokinase 1.5 1.3 NO
PDGFB platelet-derived growth factor beta polypeptide 1.5* -1.2 NO
DHRS4L2 dehydrogenase/reductase (SDR family) member 4 like 2 -1.5* -1.2 NO
TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 -1.7* 1.0 NO
S100A8 S100 calcium binding protein A8 1.5 2.5 NO
LYZ lysozyme 1.2 1.8 NO
SNCA synuclein, alpha 1.2* 2.0 NO























Fig. 2. Heat-map of putative myokines induced in the acute exercise study with a fold change (FC)  1.5. Heat-map showing the 29 most highly induced genes
encoding secreted proteins. Genes were divided into 3 categories: significantly induced in both legs, significantly induced in exercising (E) leg, and significantly
induced in nonexercising (NE) leg. Muscle-specific gene expression was verified by BioGPS and is indicated for all putative myokines. *P  0.05, #P  0.1
between the legs; paired t-test was performed for the difference between the legs for n  7. **Genes selectively expressed in cardiomyocytes and smooth muscle
cells (BioGPS), ?not present in BioGPS. E leg n  9, NE leg n  7.
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Plasma measurement of known and new myokines. We measured
IL-6, IL-18, IL-15, BDNF, CCL2 (MCP-1), and VEGF in plasma of
the acute exercise study using a multiplex immunoassay as described
by Schipper et al. (36). CYR61, CXCL2 (USCN Life Science,
Houston, TX), and CX3CL1 (fractalkine; R&D Systems, Minneapo-
lis, MN) were measured by enzyme-linked immunosorbent assay
(ELISA).
Bioinformatics tools used for microarray analysis. Using an inter-
quartile range  0.5, we selected 821 genes from the acute exercise
dataset and used them for further analysis. Those genes showed the
largest variability throughout the experiment. For the plasma levels,
values measured at T0 and T1 were used as input. MixOmics, an R
package (18), was used to perform sparse partial least square regres-
sion (sPLS) to assess the relationship between plasma parameters and
gene expression. A canonical sPLS was used. Furthermore, a hierar-
chical clustering was performed on the sPLS results. Clusters were
extracted in R and analyzed with Ingenuity (http://www.ingenuity.
com) and ClueGO (5). Correlation of the top 200 most variable genes
were calculated with GItools (29).
Statistical analysis. Statistical analysis for the plasma myokines
and qPCR data was performed with SPSS (version 18; SPSS,
Chicago, IL). Differences between the different time points for the
plasma parameters were analyzed by a repeated measure one-way
ANOVA. Gene expression differences between T0 and T1 were
evaluated by a paired t-test. Gene expression differences between the
legs for the changes from T0 to T1 were evaluated by a paired t-test.
Data are means  SD, and P  0.05 was considered statistically
significant.
RESULTS
Acute exercise-induced myokines determined by secretome
analysis. One hour of one-legged cycling significantly changed
the expression of 938 genes in the exercising leg (P  0.01,
Fig. 3. Verification of microarray data by quantitative (q)PCR. Gene expression of selected novel (A) and known (B) myokines as determined by qPCR in the
acute exercise study. Signal log ratios (SLR) for both legs are displayed. Expression values were normalized by the housekeeping gene GAPDH. *P  0.05,
#P  0.1. Depicted are means  SE, n  11.
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n  9) compared with 209 genes in the nonexercising leg (P 
0.01, n  7). The overall analysis of the whole genome
expression data has been published elsewhere (8). The signif-
icantly changed genes were further analyzed to identify poten-
tial candidate myokines by so-called secretome analysis, which
involved using GO Classification and SignalP predicting tools
to screen the microarray dataset for genes likely encoding
secreted proteins. We found that 80 genes encoding secreted
proteins were changed in the exercising leg, 52 of which were
upregulated and 28 were downregulated (Fig. 1, P  0.01). In
the nonexercising leg, 17 genes encoding secreted proteins
were significantly changed (12 up- vs. 5 downregulated, Fig.
1). Upregulated genes showed an overlap between the exercis-
ing and nonexercising leg, which was not observed for the
downregulated genes. The complete list of putative myokines
can be found in the supplemental dataset.1 We further reduced
the number of exercise-induced myokines by applying a fold-
change (FC) cut-off of 1.5, resulting in 29 putative myokines.
The 1.5 FC cut-off was applied to narrow our search for new
systemic myokines, based on the notion that minor changes in
gene expression are less likely to have physiological conse-
quences. Only two putative myokines were significantly regu-
lated in both legs, while a further 23 putative myokines were
specifically regulated in the exercising leg (Fig. 2). Four
myokines were specifically regulated in the nonexercising leg.
Putative myokines with the highest FC were ADAMTS1 (ex-
ercising leg FC 4.9), ANGPTL4 (exercising leg FC 1.6, non-
exercising leg 3.5), and S100A8 (nonexercising leg FC 2.5).
The set of myokines that was significantly induced in the
exercising leg includes the chemokines CXCL2, CX3CL1
(fractalkine), and CCL2. CCL2 has already been reported as a
myokine whose mRNA and protein levels are increased locally
in the muscle during exercise (46, 48). Interestingly, only one
putative myokine (ANGPTL4) was more highly induced in the
nonexercising compared with the exercising leg. The changes
in gene expression of selected putative myokines as determined
by microarray were confirmed by qPCR (Fig. 3A), except for
VEGFA.
We examined whether any of the 29 exercise-induced genes
encoding secreted proteins were selectively expressed in mus-
cle, as assessed with BioGPS (http://biogps.org). Only two of
the putative myokines were expressed selectively in muscle,
THBS1 and CTGF, which showed the highest expression in
smooth muscle and cardiomyocytes (Fig. 2).
Several known myokines, including IL-6, IL-8, IL-15, and
FNDC5 (Irisin) did not appear in the total list of 96 signifi-
cantly changed genes that encoded secreted proteins. Detailed
analysis revealed that most known myokines were indeed not
significantly changed in either the exercising or nonexercising
leg (Table 2). IL-6 and FGF21 were both significantly induced
in the exercising leg but, due to their low expression signal, did
not pass the filtering process. To confirm the microarray results
we performed qPCR on a selection of known myokines (Fig.
3B), which largely confirmed the microarray results. Indeed,
IL-15 and FNDC5 were not significantly changed, and a trend
was observed for increased expression of IL-6 in the exercising
leg.
Changes in plasma levels of myokines by acute exercise.
Based on the list of 29 putative myokines altered 1.5-fold, we
created a short list of promising myokines that we measured in
plasma by either ELISA or multiplex immunoassay.
In line with the increased mRNA levels, plasma levels of
CCL2 and CX3CL1 increased during one-legged exercise and
during recovery, which was consistently observed in all sub-
jects (Fig. 4A). Despite increased mRNA expression, CYR61
and CXCL2 did not show any change in plasma levels in
response to exercise. Plasma VEGFA levels seemed to be
slightly increased by exercise, but the effect did not reach
statistical significance (Fig. 4A). Also, plasma levels of the
known myokines IL-6, IL-8, IL-15, and BDNF did not change
during or after exercise (Fig. 4B).
Relationship between plasma myokine levels and muscle
gene expression in acute exercise. To better understand the
underlying molecular basis for the changes in plasma levels of
the putative myokines, we determined the correlation between
plasma levels of myokines and genes regulated in the exercis-
ing leg with sPLS followed by clustering (Fig. 5A). This analysis
showed that CX3CL1 and CCL2 are part of one cluster, which
also includes BDNF, VEGF, and to a lesser extent IL-15. Those
five myokines are highly correlated with a subset of 242 genes
shown in the top left corner of the heat-map in Fig. 5. To gain
insight into the function and regulation of these genes, upstream
regulator analysis was performed with Ingenuity, which indicates
which regulators (transcription factor, cytokine, enzyme complex)
might be responsible for the observed gene expression changes
(Fig. 5B). The analysis yielded upstream regulators mainly in-
volved in metabolism (e.g., CREB1, ERK), growth/hypertrophy
(e.g., TGFB1, STAT3), and inflammation (IL-1beta, TNFalpha).
In addition, a GO category analysis was performed using ClueGO
(Fig. 5C), which yielded the specific processes that were repre-
sented by the genes highly correlated with the five myokines:
metabolism, inflammation, signaling, growth/tissue development/
hypertrophy, cell death.
We further extended this analysis by correlating gene ex-
pression of myokines with gene expression of 200 highly
regulated genes in the exercising leg. This resulted in a subset
of 44 genes having a correlation coefficient 0.5 with the
CX3CL1 or CCL2 gene, or both (Fig. 6). We found that 68%
of those genes were also present in the subset generated by
correlating plasma levels and gene expression. Similarly, the
upstream regulators for the 44 genes largely overlap with the
upstream regulators for the genes clustering with plasma
CX3CL1 and CCL2. To assess the similarities between exer-
cising and nonexercising leg, we performed sPLS using Mix-1 The online version of this article contains supplemental material.
Table 2. Microarray results of majority of currently known
myokines for the exercising and nonexercising leg
Gene Name FC Exercising Leg P Value FC Nonexercising Leg P Value
IL6 1.6 0.0002 1.2 0.1
IL8 1.0 0.7 1.1 0.3
IL15 1.1 0.2 1.1 0.2
BDNF 1.1 0.2 1.1 0.2
IL7 1.1 0.2 1.1 0.3
LIF 1.1 0.5 1.0 0.9
FGF21 1.1 0.01 1.0 0.9
FNDC5 1.0 0.7 1.1 0.2
Exercising leg, n  9; nonexercising leg, n  7. FC, fold change.
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Omics on the nonexercising (Fig. 7). Again, a clear cluster was
obtained that exhibited a high correlation with CX3CL1,
CCL2, BDNF, and VEGF. Genes in this cluster showed
marked overlap (68%) with the gene cluster from the exercis-
ing leg. Also, GO categories determined with ClueGO were
highly similar between the two gene clusters.
Comparison between secretome analysis of acute exercise
versus exercise training. Microarray analysis was performed,
and the 20 most highly induced genes are depicted in Fig. 8A.
Secretome analysis of the exercise training intervention re-
sulted in a list of 69 genes potentially coding for myokines,
which can all be found in the supplemental dataset. A large
Fig. 4. Plasma levels of myokines. Selected known myokines were measured in plasma of the acute exercise study by multiplex immunoassay or ELISA. Black
bar between time points 0 and 1 indicates exercise period. Depicted are means  SE, *P  0.05 compared with baseline, n  12.
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subset of those 69 genes encoded proteins that play a role in the
extracellular matrix (ECM) of the cell. In general the fold-
induction of the putative myokines was much lower in exercise
training compared with acute exercise (Fig. 8A), and the
majority of putative myokines was upregulated (Fig. 8C).
Although the total number of putative secreted proteins was
comparable between exercise training and acute exercise, the
overlap was relatively small, with only 12 genes shared be-
tween the two exercise modalities (Fig. 8B). All 13 genes
exhibited a very modest change in expression, which for most
genes went in opposite directions by acute exercise and exer-
cise training (Fig. 8D). Only SHE, ENG, EFNA1, and ACTN4
were upregulated by both acute exercise and exercise training.
DISCUSSION
Here we applied secretome analysis to identify novel
myokines induced by acute exercise or exercise training. We
are unaware of any other unbiased screenings for novel
myokines that used muscle biopsies from exercising humans
as starting material. Our results reveal a number of exercise-
induced myokines that are secreted into plasma, including
CX3CL1 and CCL2. In contrast, one-legged exercise had no
effect on plasma levels of several known myokines, includ-
ing IL-6, IL-8, and IL-15. Intriguingly, we observed only
very minor overlap between the secretome analysis of acute
exercise and exercise training, reflecting the very different
effects of acute exercise and exercise training on gene
expression in muscle.
CCL2 and the newly discovered myokine CX3CL1 are
well-known chemokines. CCL2 is a key mediator of macro-
phage recruitment during the inflammatory response and was
reported to be increased at the mRNA level by resistance
exercise (21, 48) and moderately intensive cycling (46). Im-
munohistochemical studies indicate that CCL2 protein is pres-
ent in skeletal muscle, being colocalized with satellite cells and



























Fig. 5. Hypertrophy, metabolism, and inflammation characterize the extracted set of genes resulting from a sparse partial least square (sPLS) regression analysis
of exercising leg gene expression and myokine plasma levels. sPLS was performed on the most variable genes [interquartile range (IQR)  0.5] and myokine
plasma levels of the acute exercise study and hierarchically clustered (A). A cluster highly correlating with CCL2 and CX3CL1 was extracted and analyzed with
Ingenuity (B) and ClueGO (C).
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plays a role in leukocyte adhesion (37) and is involved in
macrophage-directed rescuing of skeletal muscle cells from
apoptosis (39). Both CCL2 and CX3CL1 are involved in acute
skeletal muscle injury and regeneration by attracting macro-
phages and other immune cells recruited for repair and growth
of skeletal muscle and may play a role in the adaptive response
to exercise (31). Infiltration of macrophages is believed to be
crucial for exercise-induced hypertrophy, and it is possible that
CX3CL1 and CCL2 play a role in this process (11). To what
extent exercise-induced local changes in CX3CL1 and CCL2
influence skeletal muscle insulin sensitivity will be the subject
of our future investigations. Existing data suggest that CCL2 is
negatively related to insulin sensitivity (16, 24) and increased
CCL2 plasma levels are associated with diabetes (30). The
influence of CX3CL1 on insulin signaling is not known, but
plasma levels of CX3CL1 were found to be elevated in subjects
with Type 2 diabetes (38).
Since both chemokines are expressed and secreted from a
wide variety of tissues, as is true for all myokines identified so
far, it is unclear whether the changes in plasma levels are
exclusively driven by increased production in skeletal muscle.
Expression profiling of human primary myotubes reveals that
expression levels of CCL2 in skeletal muscle are extremely
high (data not shown, GSE18589; ranked 145 out of 19,741
genes), which is supported by BioGPS (http://biogps.org).
CX3CL1 expression levels in primary myotubes are markedly
lower. Staining of CCL2 in skeletal muscle biopsies showed
CCL2 to be present in skeletal muscle cells (14). At the same
time, we cannot rule out the possibility that macrophages or
other cell types present in the biopsies play a role in the
induction of CCL2 and CX3CL1 gene expression by exercise.
It is important to note that the number of macrophages in
resting skeletal muscle is limited and that infiltration of mac-
rophages reaches its peak 24 h postexercise (45). Accordingly,
it can be argued that myocytes most likely account for the
elevated CCL2 and CX3CL1 mRNA levels after acuter exer-
cise.
Several studies have shown that IL-6 is increased upon
endurance exercise, both at the mRNA and plasma level (12,
42, 43). We found a significant increase in IL-6 mRNA in the
exercising leg, which was not associated with any change in
plasma IL-6 levels, suggesting a more local role of IL-6. It
should be emphasized that IL-6 mRNA levels were very low
and failed to pass the initial filtering of the microarray data.
The reason for the discrepancy with several published studies
is unclear (12, 42, 43). One potential explanation is that the
size of muscle mass used in one-legged cycling was insuffi-
cient to elicit any changes in IL-6 plasma levels. Another
explanation is that the exercise intensity was relatively modest
(50% Wmax vs. 75% V̇O2 max) compared with other studies
with similar exercise duration (20, 34), although we did ob-
serve an increase in IL-6 mRNA. Recent data showed that
carbohydrate ingestion attenuates the increase in plasma IL-6
but not skeletal muscle IL-6 mRNA during exercise in humans
(40). Overall, the degree of correlation between muscle IL-6
mRNA expression and plasma IL-6 levels is clearly dependent
on the specific exercise conditions.
Of all the other proteins that have been suggested to be
myokines, only FGF-21 showed a significant increase in
mRNA levels in response to exercise, although the magnitude
of induction was very modest. Limited research has been
performed on FGF-21 as a myokine (15), and there are no
reports indicating that exercise increases FGF-21 mRNA lev-
els. Limited information is also available on other putative
myokines, including IL-8, IL-15, BDNF, and LIF, and their
induction in skeletal muscle during exercise has not been
Genes  correlating > 0.5 with CX3CL1 and MCP-1 genes



























Fig. 6. Genes showing a high correlation with CX3CL1 and CCL2. A correlation analysis was performed using GItools on gene expression of the 200 most
variable genes and genes coding for myokines of the acute exercise study; 44 genes had a correlation coefficient  0.5 with the CX3CL1 and/or CCL2 gene
expression. Overlap was determined between those 44 genes and the subset of genes clustering with CCL2 and CX3CL1 plasma levels, highlighted in the
heat-map in Fig. 5 (middle) and analyzed for upstream regulators with Ingenuity (right).
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consistently demonstrated (7, 9, 47). The latter observation
may be related to differences in type, intensity, or duration of
exercise. Recently, irisin was discovered as a novel muscle-
specific protein that is induced by exercise-training via the
transcriptional coactivator PGC1-. Irisin was proposed to be
released into the circulation and was found to stimulate brown-
ing and associated thermogenesis in subcutaneous fat in mice
(6). It was demonstrated that plasma levels of irisin are induced
specifically by exercise training and not upon acute exercise,
which is consistent with our observation that acute exercise did
not alter expression of the gene coding for irisin (FNDC5).
However, in the meantime serious concerns have arisen about
the sequence of human FNDC5 and the secretion of irisin into
human blood (32). For this reason we did not attempt to
measure plasma irisin levels in our study.
The main outcome of the mixomics analysis was the emer-
gence of a clear cluster of genes correlating with plasma levels
of CCL2 and CX3CL1. Interestingly, only CCL2 and CX3CL1
correlated with a clear cluster, whereas much weaker correla-
tions were seen for other myokines. Combined with the ob-
served induction of CCL2 and CX3CL1 mRNA, these data
suggest that changes in plasma levels of CCL2 and CX3CL1
are driven by changes in muscle gene expression. Additionally,
the processes characterizing the genes present in the CCL2 and
CX3CL1 cluster nicely correspond with the known role of
CX3CL1 and CCL2 in growth and hypertrophy, inflammation,
and apoptosis (11, 31, 39), pointing to a potential role of CCL2
and CX3CL1 in exercise-induced gene expression changes.
There was only very limited overlap between the putative
myokines altered by acute exercise compared with myokines
altered by exercise training. In general, acute exercise and
exercise training have very different effects on gene expres-
sion, with acute exercise eliciting a more stress-like response
compared with a chronic adaptive response to exercise train-
ing. Whereas the adaptive response causes the improvements
in exercise capacity and cardiometabolic fitness, it is still
unclear which type of response is most important for confer-
ring the positive effect of exercise on other parameters, such as
insulin sensitivity. Based on this notion, it is difficult to define







GO Categories in NE leg
Exercising leg Non-exercising leg
Fig. 7. The genes in the NE leg correlating with
CX3CL1 and CCL2 plasma levels correspond
largely to the set of genes of E leg. sPLS of both
legs is shown; for both legs, expression values of
the most variable genes (IQR  0.5) and myokine
plasma levels were used (top). Both clusters were
extracted and overlapped (middle). The nonexer-
cising cluster was analyzed with Ingenuity
(bottom).
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pharmacological target for metabolic disturbances such as
insulin resistance. Interestingly, a large part of the genes
resulting from the secretome analysis of the exercise training
study encoded ECM proteins. Although ECM proteins are
secreted out of the cells, they are unlikely to have an effect on
distant cells or tissues. However, they could play a more
indirect role in endocrine signaling by influencing the release
and activation of other proteins.
One of the major limitations of our approach is that it
precludes identification of novel myokines that are regulated
exclusively at the posttranscriptional level. Another limitation





























































Fig. 8. Overlap between acute exercise-induced and training-induced myokines. A: top 20 upregulated genes during exercise training. B: Venn diagram of overlap
of putative myokines induced by acute exercise and exercise training. C: number of putative myokines up- or downregulated by acute exercise and exercise
training. D: bar chart of the expression of the overlapping putative myokines. Acute exercise n  9, training n  18.
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from two separate, relatively small sets of subjects. Subjects
participating in both studies would have made the analysis
more powerful. Despite the relatively small sample sizes, in
both studies the changes identified were very consistent be-
tween the subjects.
In conclusion, we identified several myokines that may be
involved in cross talk between skeletal muscle and other
organs. The most promising candidates were CX3CL1 and
CCL2 (MCP-1), which were increased at the gene expression
level and in blood plasma. Furthermore, there was no substan-
tial overlap of induced genes encoding potentially secreted
proteins between acute exercise and exercise training, empha-
sizing the difference in response to acute exercise and exercise
training.
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